Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Entrada Therapeutics (TRDA)

Annual Return

Over the past 3 years, TRDA has had an average annual return of -18.64%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Oct 29, 2021, TRDA has had an average annual return of -24.50%, underperforming the benchmark SPY, which returned +12.91% annual.

202620252024202320222021
-36.00%-40.55%+14.57%+11.62%-21.03%-28.52%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+11.30%+4.27%+5.78%+6.98%-47.63%-6.94%-36.00%
2025-22.26%-11.17%-24.27%+0.98%-16.76%-11.57%-12.51%-6.97%+6.04%+19.82%+47.76%+0.09%-40.55%
2024-3.44%-9.20%+7.10%-16.36%+30.54%-7.88%+15.58%+7.46%-9.72%+7.27%+16.04%-13.08%+14.57%
2023-10.13%+4.95%+13.71%-19.24%-2.13%+32.12%+14.73%-15.26%+7.34%+1.33%-19.00%+16.36%+11.62%
2022-35.34%+9.58%-22.59%-36.32%+13.06%+80.16%+5.07%-1.33%+24.79%+44.62%-34.31%-9.69%-21.03%
2021+0%+24.34%-42.51%-28.52%

Drawdown analysis of Entrada Therapeutics (TRDA)

The maximum drawdown for the TRDA was -85.66%, occurring on Aug 11, 2025. This drawdown has not yet recovered.

The current TRDA drawdown is -81.20%.

Since Oct 29, 2021 TRDA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-85.66%Nov 17, 2021934Aug 11, 2025OngoingOngoingOngoing
-6.01%Oct 29, 20211Nov 1, 20211Nov 2, 20212
-2.87%Nov 2, 20213Nov 5, 20211Nov 8, 20214
-0.70%Nov 15, 20211Nov 16, 20211Nov 17, 20212
-0.43%Nov 11, 20211Nov 12, 20211Nov 15, 20212
-0.04%Nov 9, 20211Nov 10, 20211Nov 11, 20212